From: Receptor binding specificity of recent human H3N2 influenza viruses
Glycan # | Glycan | Percent of total binding | |||||
---|---|---|---|---|---|---|---|
 |  | 369/05 | 1992/05 | 370/05 | 323/03 | Wyoming | Philippines |
247 | Neu5Acα2-6Galβ1-4GlcNAcβ1-3Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-4(Fucα1-3)GlcNAcβ-Sp0 | 16 | 27 | 20 | 19 | 31 | 6 |
246 | Neu5Acα2-6Galβ1-4GlcNAcβ-Sp8 | 16 | 13 | 14 | 16 | 6 | 6 |
248 | Neu5Acα2-6Galβ1-4GlcNAcβ1-3Galβ1-4 GlcNAcβ-Sp0 | 15 | 26 | 17 | 16 | 22 | 6 |
243 | Neu5Acα2-6GalNAcβ1-4GlcNAcβ-Sp0 | 15 | 18 | 14 | 18 | 17 | 6 |
244 | Neu5Acα2-6Galβ1-4 [6OSO3]GlcNAcβ-Sp8 | 12 | 10 | 13 | 13 | 6 | 6 |
245 | Neu5Acα2-6Galβ1-4GlcNAcβ-Sp0 | 11 | 3 | 14 | 16 | 4 | 6 |
54 | Neu5Acα2-6Galβ1-4GlcNAcβ1-2Manα1-3 (Neu5Acα2-6Galβ1-4GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAc-Sp8 | 4 | 0 | 4 | 1 | 0 | 6 |
53 | Neu5Acα2-6Galβ1-4GlcNAcβ1-2Manα1-3 (Neu5Acα2-6Galβ1-4GlcNAcβ1-2Manα1-6) Manβ1-4GlcNAcβ1-4GlcNAc-Gly | 3 | 0 | 4 | 1 | 0 | 6 |
242 | Neu5Acα2-6GalNAcα-Sp8 | 1 | 0 | 0 | 0 | 3 | 6 |
203 | NeuAcα2-8NeuAcα2-8NeuAcα2-8NeuAcα2-3(GalNAcβ1-4)Galβ1-4Glcβ-Sp0 |  |  |  |  | 3 |  |
231 | Neu5Acα2-3Galβ1-4(Fucα1-3)GlcNAcβ-Sp8 |  |  |  |  | 4 |  |
253 | Neu5Acα2-8Neu5Acα2-3Galβ1-4Glcβ-Sp0 |  |  |  |  | 4 |  |